1146. Thrombocytosis in Infants with Congenital Cytomegalovirus Infection Being Treated with Valganciclovir

BACKGROUND: Congenital CMV (cCMV) is associated with sensorineural hearing loss and neurodevelopmental disabilities. Infants with symptomatic cCMV infection benefit from 6 months of oral valganciclovir (vGCV) therapy. Neutropenia, thrombocytopenia, and hepatotoxicity are adverse effects vGCV, for wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Murtagh, Kathleen, Toia, Jacquie, Scardina, Tonya, Rowley, Anne H, Mithal, Leena B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776892/
http://dx.doi.org/10.1093/ofid/ofaa439.1332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776892/
http://dx.doi.org/10.1093/ofid/ofaa439.1332

Ejemplares similares